Biohacking, also known as do-it-yourself (DIY) biology, which gives everyone including communities, individuals, research institutes and small group organizations, the ability to deconstruct and reconstruct biology using simple kits or supplements for the purpose of not only achieving their immediate outcomes as well as contributing to solving larger issues.

The outbreak of COVID-19 virus has positively influenced affected the biohacking industry. The COVID-19 crisis has resulted in a surge in the market growth for the pharmaceutical industries. Several R&D activities have been conducted by companies to produce suitable drugs or vaccines to curb the crisis, which if projected to augment the market growth.

Various government of dominant players in the biohacking industry is increasing their investments in such industries, so that, it is possible for companies to come up with viable and potable drugs to limit and gradually eradicate the virus.

Growing innovative trends towards neuro-nutrition as well as increasing awareness of biohacking in the health & wellness space are likely to boost the product demand.

• Significant technological growth coupled with the internet of things (IoT) penetration in consumer electronics and healthcare also augments the industry growth.

• Furthermore, the rising demand for smart drugs and devices to cater to the quality healthcare needs among the population as well as the high prevalence of chronic disorders are further expected to bolster the market expansion.

By type, the biohacking market has been segmented into pharmaceutical & biotechnological companies, forensic laboratories, and others.

• Under these, the pharmaceutical & biotechnological companies segment held a considerable market share in 2020 and is likely to register the fastest CAGR during the review period.

• This is mainly attributed to the increasing geriatric population.

• Also, surging demand for devices for monitoring the heart rate, blood sugar level, and body movement is proliferating the segment growth.

By region, the North American market witnessed the highest market share in 2020 and is estimated to grow at a substantial CAGR during the assessment period. This is mainly ascribed to a surge in healthcare expenditure, technologically advanced healthcare infrastructure, and well-established healthcare companies. Moreover, growing healthcare expenditure and improving standards of living with large population growth further boosts regional growth.

Key Players:               

• Fitbit Inc. (The U.S),

• Apple (The U.S),

• HVMN Inc (The U.S),

• The Odin (The U.S),

• Thync Global Inc (The U.S),

• Synbiota (Canada),

• MoodMetric (The U.S),

• InteraXon Inc. (Canada),

• Behavioral Tech (The U.S), and

• Grindhouse Wetware (The U.S).